KAS
TEVA icon

Kestra Advisory Services’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Kestra Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
46,085
-1,303
-3% -$43.4K 0.01% 1507
2026
Q1 		$1.43M Buy
47,388
+1,031
+2% +$33.2K 0.01% 1501
2025
Q4 		$1.45M Buy
46,357
+4,482
+11% +$110K 0.01% 1413
2025
Q3 		$846K Sell
41,875
-1,173
-3% -$20.6K ﹤0.01% 1697
2025
Q2 		$721K Buy
43,048
+4,570
+12% +$73.7K ﹤0.01% 1705
2025
Q1 		$591K Sell
38,478
-5,994
-13% -$107K ﹤0.01% 1705
2024
Q4 		$980K Buy
44,472
+6,482
+17% +$118K 0.01% 1432
2024
Q3 		$685K Sell
37,990
-5,994
-14% -$105K ﹤0.01% 1559
2024
Q2 		$638K Buy
43,984
+4,363
+11% +$67.2K ﹤0.01% 1618
2024
Q1 		$559K Buy
+39,621
New +$499K ﹤0.01% 1598
2023
Q2 		– Sell
-10,251
Closed -$90.7K – 2185
2023
Q1 		$90.7K Sell
10,251
-10,115
-50% -$100K ﹤0.01% 1963
2022
Q4 		$186K Buy
20,366
+5,380
+36% +$46.9K ﹤0.01% 2043
2022
Q3 		$121K Sell
14,986
-24,855
-62% -$220K ﹤0.01% 1959
2022
Q2 		$300K Buy
39,841
+29,510
+286% +$257K ﹤0.01% 1625
2022
Q1 		$97K Sell
10,331
-2,568
-20% -$21.4K ﹤0.01% 1934
2021
Q4 		$103K Buy
12,899
+793
+7% +$7.16K ﹤0.01% 1936
2021
Q3 		$118K Buy
12,106
+1,507
+14% +$14.1K ﹤0.01% 2043
2021
Q2 		$105K Sell
10,599
-7,238
-41% -$76.6K ﹤0.01% 1950
2021
Q1 		$206K Sell
17,837
-35,974
-67% -$413K ﹤0.01% 1717
2020
Q4 		$517K Buy
53,811
+17,601
+49% +$169K 0.01% 1189
2020
Q3 		$327K Buy
+36,210
New +$383K 0.01% 1067

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Kestra Advisory Services's TEVA Position: Q2 2026 in Review

Kestra Advisory Services reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 2.7% in Q2 2026, selling an estimated $43.4K and leaving 46,085 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #1507.

Kestra Advisory Services first reported a position in TEVA in Q3 2020 and has held it in 21 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Kestra Advisory Services held 46,085 shares of Teva Pharmaceutical Industries Limited worth $1.56M as of Q2 2026.
  • Kestra Advisory Services sold 1,303 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $43.4K.
  • Teva Pharmaceutical Industries Limited made up 0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1507 holding.
  • Kestra Advisory Services first reported a position in Teva Pharmaceutical Industries Limited in Q3 2020 and has held it in 21 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.